Document is current
Any future updates will be listed below
-
Authors
Saliba, Faouzi https://orcid.org/0000-0002-2058-9217
Bañares, Rafael https://orcid.org/0000-0002-0412-8437
Larsen, Fin Stolze https://orcid.org/0000-0003-2205-8265
Wilmer, Alexander
Parés, Albert https://orcid.org/0000-0002-5413-9687
Mitzner, Steffen
Stange, Jan
Fuhrmann, Valentin
Gilg, Stefan
Hassanein, Tarek https://orcid.org/0000-0002-9157-0329
Samuel, Didier https://orcid.org/0000-0001-9481-3616
Torner, Josep
Jaber, Samir https://orcid.org/0000-0002-7257-8069
-
Funding
Funding for this research was provided by:
Baxter International
- License Information
-
More Information
Article History
Received: 3 April 2022
Accepted: 24 June 2022
First Online: 6 September 2022
Declarations
:
: FS has received speaker’s honoraria and/or research grants from Novartis, Astellas, Chiesi, Gilead, Merck Sharp and Dohme, Neovie, Biotest and Baxter. RB has received speaker’s honoraria and/or research grants from Gilead, abbvie, Janssen, Gore Baxter. FL has nothing to declare. AW has no conflict of interest. AP has received grant funding, personal fees, and advisory board fees from Intercept Pharmaceuticals and Genfit; advisory board fees and fees for teaching from Novartis; and personal fees from CymaBay Therapeutics and Inova Diagnostics. SM has received speaker`s honoraria and/or research grants from Amgen, Astellas, Baxter, BMS/Pfizer, CytoSorbents, Pentracor, Vifor. JS is chairman of the board of Albutec GmbH. VF declare presentations for Fresenius, Baxter, ADVITOS, CSL-Behring, Merz, Advisory board. SG declare no conflict of interest. TH is consultant for DIALIVE. On advisory committee and received consultancy from AbbVie, Bristol-Myers Squibb, Gilead, Malinckrodt, Merck, and Organovo. Received research grants from AbbVie, Allergan, Amarex/Cytodyn, Astra Zeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, CARA, DURECT Corporation, Enanta, Galectin, Gilead, Grifols, Intercept, Merck, Mirum, Novartis, Novo Nordisk, Pfizer, Salix Pharmaceuticals, Sonic Incytes, and Terns Pharmaceuticals. DS received research grants Astellas and honoraria from Goliver and Biotest. JT, declare no conflict of interest. JT declares no conflict of interest. SJ declares consulting fees from Drager, Fresenius-Xenios, Medtronic, Mindray and Fisher & Paykel.
